These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28263835)
1. Plant-expressed Hepatitis B core antigen virus-like particles: Characterization and investigation of their stability in simulated and pig gastro-intestinal fluids. Berardi A; Lomonossoff GP; Evans DJ; Barker SA Int J Pharm; 2017 Apr; 522(1-2):147-156. PubMed ID: 28263835 [TBL] [Abstract][Full Text] [Related]
2. High stability of plant-expressed virus-like particles of an insect virus in artificial gastric and intestinal fluids. Berardi A; Castells-Graells R; Lomonossoff GP Eur J Pharm Biopharm; 2020 Oct; 155():103-111. PubMed ID: 32805362 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety. Schödel F; Peterson D; Milich D Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676 [TBL] [Abstract][Full Text] [Related]
4. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide. Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575 [TBL] [Abstract][Full Text] [Related]
5. Stability of plant virus-based nanocarriers in gastrointestinal fluids. Berardi A; Evans DJ; Baldelli Bombelli F; Lomonossoff GP Nanoscale; 2018 Jan; 10(4):1667-1679. PubMed ID: 29231944 [TBL] [Abstract][Full Text] [Related]
6. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348 [TBL] [Abstract][Full Text] [Related]
7. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083 [TBL] [Abstract][Full Text] [Related]
8. The hepatitis nucleocapsid as a vaccine carrier moiety. Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855 [TBL] [Abstract][Full Text] [Related]
10. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129 [TBL] [Abstract][Full Text] [Related]
11. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes. Schödel F; Peterson D; Hughes J; Wirtz R; Milich D J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391 [TBL] [Abstract][Full Text] [Related]
12. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination. Schödel F; Peterson D; Hughes J; Milich DR Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864 [TBL] [Abstract][Full Text] [Related]
13. Comparative immunogenicity of hepatitis B virus core and E antigens. Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543 [TBL] [Abstract][Full Text] [Related]
14. Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2. Arora U; Tyagi P; Swaminathan S; Khanna N J Nanobiotechnology; 2012 Jul; 10():30. PubMed ID: 22794664 [TBL] [Abstract][Full Text] [Related]
15. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Arora U; Tyagi P; Swaminathan S; Khanna N Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049 [TBL] [Abstract][Full Text] [Related]
16. Adsorption of virus-like particles on ion exchange surface: Conformational changes at different pH detected by dual polarization interferometry. Yang Y; Mengran Yu ; Zhang S; Ma G; Su Z J Chromatogr A; 2015 Aug; 1408():161-8. PubMed ID: 26189208 [TBL] [Abstract][Full Text] [Related]
17. High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors. Diamos AG; Mason HS Protein Expr Purif; 2018 Nov; 151():86-92. PubMed ID: 29908914 [TBL] [Abstract][Full Text] [Related]
18. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine. Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667 [TBL] [Abstract][Full Text] [Related]
19. Physicochemical behaviour of WPI-stabilized emulsions in in vitro gastric and intestinal conditions. Li J; Ye A; Lee SJ; Singh H Colloids Surf B Biointerfaces; 2013 Nov; 111():80-7. PubMed ID: 23792544 [TBL] [Abstract][Full Text] [Related]
20. Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing. Zahid M; Lünsdorf H; Rinas U Vaccine; 2015 Jul; 33(31):3739-45. PubMed ID: 26079614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]